Published in Acta Clin Belg on January 01, 1995
KRAS wild-type state predicts survival and is associated to early radiological response in metastatic colorectal cancer treated with cetuximab. Ann Oncol (2007) 5.68
Phase III trial of gemcitabine plus tipifarnib compared with gemcitabine plus placebo in advanced pancreatic cancer. J Clin Oncol (2004) 3.56
Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by gene MAGE-3 and presented by HLA-A1. Int J Cancer (1999) 3.19
Tumor regression responses in melanoma patients treated with a peptide encoded by gene MAGE-3. Int J Cancer (1995) 2.28
Phase II study of preoperative oxaliplatin, capecitabine and external beam radiotherapy in patients with rectal cancer: the RadiOxCape study. Ann Oncol (2005) 1.95
Expression of MAGE genes in primary and metastatic cutaneous melanoma. Int J Cancer (1995) 1.81
International Consensus Conference on High-Dose Therapy with Hematopoietic Stem Cell Transplantation in Aggressive Non-Hodgkin's Lymphomas: report of the jury. J Clin Oncol (1999) 1.76
An open-label, single-arm study assessing safety and efficacy of panitumumab in patients with metastatic colorectal cancer refractory to standard chemotherapy. Ann Oncol (2007) 1.58
Immune reconstitution and immunotherapy after autologous hematopoietic stem cell transplantation. Blood (1998) 1.55
Phase III double-blind placebo-controlled study of farnesyl transferase inhibitor R115777 in patients with refractory advanced colorectal cancer. J Clin Oncol (2004) 1.46
Parvovirus B19 and blood products. Lancet (1994) 1.44
Dose-dependent interleukin-3 stimulation of thrombopoiesis and neutropoiesis in patients with small-cell lung carcinoma before and following chemotherapy: a placebo-controlled randomized phase Ib study. J Clin Oncol (1993) 1.42
Injection of allergen-antibody complexes is an effective treatment of atopic dermatitis. Dermatologica (1991) 1.39
Immunisation of metastatic cancer patients with MAGE-3 protein combined with adjuvant SBAS-2: a clinical report. Eur J Cancer (2003) 1.21
Comparative study of 3 H-thymidine labelling of the dermal infiltrate of skin allergic and irritant patch test reactions in man. Br J Dermatol (1972) 1.19
Primary anaplastic large-cell lymphoma in adults: clinical presentation, immunophenotype, and outcome. Blood (1997) 1.19
Association of progression-free survival with patient-reported outcomes and survival: results from a randomised phase 3 trial of panitumumab. Br J Cancer (2007) 1.15
Tritiated thymidine labelling of normal human epidermal cell nuclei. A comparison, in the same subjects, of in vivo and in vitro techniques. Br J Dermatol (1969) 1.11
Human herpes virus 6 infection is a hallmark of cord blood transplant in adults and may participate to delayed engraftment: a comparison with matched unrelated donors as stem cell source. Bone Marrow Transplant (2009) 1.09
Histopathological discriminant criteria between lichenoid drug eruption and idiopathic lichen planus: retrospective study on selected samples. Dermatologica (1989) 1.08
Clinical activity and benefit of irinotecan (CPT-11) in patients with colorectal cancer truly resistant to 5-fluorouracil (5-FU). Eur J Cancer (1999) 1.07
A new hematologic syndrome with a distinct karyotype: the 5 q--chromosome. Blood (1975) 1.05
Phase I/II study of preoperative cetuximab, capecitabine, and external beam radiotherapy in patients with rectal cancer. Ann Oncol (2007) 1.02
Skin granulomas due to Mycobacterium gordonae. Int J Dermatol (1987) 1.02
Bleomycin, vincristine, lomustine and dacarbazine (BOLD) in combination with recombinant interferon alpha-2b for metastatic uveal melanoma. Eur J Cancer (2003) 1.01
Resistance to cisplatin: how to deal with the problem? Eur J Cancer (1990) 1.00
Targeting retroviral vectors to CD34-expressing cells: binding to CD34 does not catalyze virus-cell fusion. Hum Gene Ther (1999) 1.00
Bee stings and acute tubular necrosis. Nephron (1982) 0.99
Confluent and reticulate papillomatosis (Gougerot-Carteaud) and pityrosporum orbiculare. Br J Dermatol (1969) 0.99
Late intensification chemotherapy with autologous bone marrow transplantation in selected small-cell carcinoma of the lung: a randomized study. J Clin Oncol (1987) 0.98
Pitfalls in the detection of disseminated non-hematological tumor cells. Ann Oncol (2000) 0.97
Features of Epstein-Barr Virus (EBV) reactivation after reduced intensity conditioning allogeneic hematopoietic stem cell transplantation. Leukemia (2011) 0.96
An epidemiological survey of virus warts of the hands among butchers. Br J Dermatol (1977) 0.96
Concentrations of patch test allergens: are we comparing the same things? Contact Dermatitis (1978) 0.95
Intra-arterial hepatic fotemustine for the treatment of liver metastases from uveal melanoma: experience in 101 patients. Ann Oncol (2006) 0.95
[Invasive and non-invasive studies of the protective action of a silicon-containing cream and its excipient in skin irritation induced by sodium laurylsulfate]. Ann Dermatol Venereol (1989) 0.93
Unreliability of carcinoembryonic antigen (CEA) reverse transcriptase-polymerase chain reaction (RT-PCR) in detecting contaminating breast cancer cells in peripheral blood stem cells due to induction of CEA by growth factors. Bone Marrow Transplant (1999) 0.93
Human equilibrative nucleoside transporter 1 (hENT1) expression is a potential predictive tool for response to gemcitabine in patients with advanced cholangiocarcinoma. Eur J Cancer (2011) 0.93
Plasmacytoid dendritic cells and Th17 immune response contribution in gastrointestinal acute graft-versus-host disease. Leukemia (2012) 0.92
Molecular analysis of a germ line-encoded idiotypic marker of pathogenic human lupus autoantibodies. J Immunol (1990) 0.92
Human ABO-incompatible living donor renal homografts. Neth J Med (1985) 0.92
Meningococcal purpura: report of 19 patients treated with heparin. J Pediatr (1973) 0.89
Nickel contact sensitivity in women and HLA antigens. Arch Dermatol Res (1980) 0.89
Spontaneous 3H-thymidine incorporation by circulating lymphocytes of normal subjects: relative proportion of T and B cells. Int Arch Allergy Appl Immunol (1977) 0.89
Simultaneous study of five candidate target antigens (CD20, CD22, CD33, CD52, HER2) for antibody-based immunotherapy in B-ALL: a monocentric study of 44 cases. Leukemia (2008) 0.89
The proliferation of cells in the dermal infiltrate of lichen planus lesions. Br J Dermatol (1973) 0.88
Patch testing with fragrances: results of a multicenter study of the European Environmental and Contact Dermatitis Research Group with 48 frequently used constituents of perfumes. Contact Dermatitis (1995) 0.88
A new way to evaluate the germinative compartment in human epidermis, using [3H]thymidine incorporation and immunoperoxidase staining of 67 K polypeptide. Br J Dermatol (1983) 0.88
[Radioautographic study of the incorporation in vitro of tritiated thymidine into normal human skin and in certain epidermal proliferations]. Pathol Eur (1970) 0.88
Contact dermatitis. A review. Contact Dermatitis (1987) 0.87
An open-label study of vandetanib with pemetrexed in patients with previously treated non-small-cell lung cancer. Ann Oncol (2008) 0.86
IL-3 and peripheral blood stem cell harvesting. Stem Cells (1993) 0.86
[Proliferative activity of cellular infiltrates in psoriasis]. Arch Belg Dermatol Syphiligr (1973) 0.86
[Cutaneous acanthamoebiasis in a lung transplant patient]. Ann Dermatol Venereol (2001) 0.85
A phase II study of irinotecan alternated with five days bolus of 5-fluorouracil and leucovorin in first-line chemotherapy of metastatic colorectal cancer. Ann Oncol (1998) 0.84
3H-thymidine labelling of epidermis and dermal infiltrate in psoriatic erythroderma. Acta Derm Venereol (1975) 0.84
Host-parasite relationships in hyperkeratotic (Norwegian) scabies: pathological and immunological findings. Br J Dermatol (1981) 0.84
Multiple lesions of molluscum contagiosum with metaplastic ossification. Am J Dermatopathol (1989) 0.83
Immunodetection of small cell lung cancer metastases in bone marrow using three monoclonal antibodies. Eur J Cancer Clin Oncol (1988) 0.83
Result of two randomized trials comparing nolatrexed (Thymitaq) versus methotrexate in patients with recurrent head and neck cancer. Ann Oncol (2001) 0.83
[Validity of the in vitro method as a technic of instantaneous labeling of skin by tritiated thymidine]. Ann Dermatol Syphiligr (Paris) (1970) 0.83
The effect of neutropenia on the cell cycle of granulocyte precursors in an in vivo culture system. Blood (1974) 0.82
Corticosteroid contact allergy: an EECDRG multicentre study. Contact Dermatitis (1996) 0.82
Patch test reactions to mite antigens: a GERDA multicentre study. Groupe d'Etudes et de Recherches en Dermato-Allergie. Contact Dermatitis (1993) 0.82
Kaposi's sarcoma during immunosuppressive therapy for atopic dermatitis. Dermatology (1997) 0.82
An outbreak of accidental vaccinia in a family. Dermatol Int (1969) 0.82
Contact sensitivity to nonoxynols as a cause of intolerance to antiseptic preparations. J Am Acad Dermatol (1989) 0.81
SDZ ASM 981 is the first non-steroid that suppresses established nickel contact dermatitis elicited by allergen challenge. Contact Dermatitis (2000) 0.81
Effects of suloctidil on platelet survival time following cardiac valve replacement. Thromb Haemost (1981) 0.81
Comparative effects of loratadine and terfenadine in the treatment of chronic idiopathic urticaria. Ann Allergy (1990) 0.81
Comparative histopathology of allergic and irritant patch test reactions in man. Current concepts and new prospects. Arch Belg Dermatol Syphiligr (1973) 0.81
Phase II study of vinorelbine in patients with androgen-independent prostate cancer. Ann Oncol (2001) 0.81
Epidemiological survey of occupational contact dermatitis of the hands in Belgium. Contact Dermatitis (1979) 0.81
Restriction fragment length polymorphisms and single germline coding region sequence in VH18/2, a duplicated gene encoding autoantibody. Mol Immunol (1993) 0.81
Outcome after reduced-intensity conditioning allogeneic SCT for AML in first complete remission: comparison of two regimens. Bone Marrow Transplant (2008) 0.80
Pseudofolliculitis of the beard and "fiddler's neck". Contact Dermatitis (1984) 0.80
Isotopic labelling of cutaneous structures. A preliminary comparsion of local in vivo and in vitro techniques applied to healthy and pathological human skin. Br J Dermatol (1969) 0.80
Recombinant interleukin-2 in metastatic renal cell carcinoma--a European multicentre phase II study. Eur J Cancer (1991) 0.80
Clinical and biological activity of the antiplatelet agent suloctidil in treatment of idiopathic recurrent vein thrombosis (I.R.V.T.). Thromb Haemost (1982) 0.80
Biology of small cell lung cancer: an overview. Eur Respir J (1990) 0.80
Primary squamous-cell carcinoma of the colon: a case report. Acta Chir Belg (1995) 0.80
Increased "in vivo" lymphocyte blastogenesis in the peripheral blood of patients with atopic dermatitis and allergic contact dermatitis. Arch Dermatol Res (1980) 0.80
Leukocyte membrane proteins in chronic lymphocytic leukemia, as studied by two-dimensional gel electrophoresis. Clin Chem (1984) 0.80
Highly purified CD34+ cells isolated using magnetically activated cell selection provide rapid engraftment following high-dose chemotherapy in breast cancer patients. Bone Marrow Transplant (2000) 0.80
Propylene glycol-induced heparin resistance during nitroglycerin infusion. Am Heart J (1985) 0.80
[Emergency surgery for massive hemorrhage from ruptured esophageal varices in the cirrhotic patient (author's transl)]. Acta Gastroenterol Belg (1974) 0.79
Haemostasis disorders in open heart surgery with extracorporeal circulation. Importance of the platelet function and the heparin neutralization. Vox Sang (1977) 0.79
Identification of a light density murine megakaryocyte progenitor (LD-CFU-M). Blood (1988) 0.79
[Autoradiographic study of nucleic acid synthesis in Malherbe's calcified epithelioma]. Dermatologica (1972) 0.79
Effects of daunorubicin and doxorubicin, free and associated with DNA, on hemopoietic stem cells. Cancer Res (1979) 0.79